In the case of gastric carcinoma, increased CD9 expression has been observed in primary tumors and metastatic lesions, and a correlation has been demonstrated with vessel invasion, lymph node metastasis, and advanced stage [56]. This evidence concerns the gene CD9 and metastatic malignant neoplasm in the lymph nodes.